Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | AMGN | GILD | CELG | VRTX |
| Company | Phasebio Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0800 | 272.14 | 67.09 | 108.01 | 404.00 |
| High | 0.0920 | 274.48 | 67.68 | 108.59 | 406.86 |
| Low | 0.0665 | 271.05 | 67.00 | 107.27 | 403.47 |
| Last | 0.0701 | 273.54 | 67.03 | 108.24 | 404.91 |
| Change | -0.0249 | +1.63 | +0.08 | +0.11 | +4.99 |
| % Change | -26.21% | +0.60% | +0.12% | +0.10% | +1.25% |
| Volume | 9,647,400 | 2,493,200 | 5,239,300 | 191,230,496 | 1,069,900 |
| 20-Day Average Volume | 3,930,150 | 2,216,500 | 6,335,280 | 16,188,930 | 977,285 |
| Previous Close | 0.0950 | 271.91 | 66.95 | 108.13 | 399.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 271.99 | 69.34 | 108.17 | 404.17 |
| 20-Day Raw Stochastic | 2.27% | 46.12% | 14.18% | 63.25% | 45.66% |
| 20-Day Relative Strength | 20.88% | 48.69% | 32.82% | 64.69% | 47.90% |
| Weighted Alpha | -91.26 | +11.45 | -20.86 | +46.30 | +17.74 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 24% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 72% Sell | 8% Buy | 88% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | +2.97% since 04/16/24 | -0.42% since 04/16/24 | -1.97% since 11/13/19 | +2.72% since 04/16/24 |
| Low | 0.0665 on 11/02/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 0.1440 on 10/27/22 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | -0.95% since 03/22/24 | -7.68% since 03/22/24 | +5.14% since 10/18/19 | -2.59% since 03/22/24 |
| Low | 0.0665 on 11/02/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 0.2250 on 10/14/22 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -11.74% since 01/23/24 | -15.66% since 01/23/24 | +13.63% since 08/20/19 | -7.91% since 01/23/24 |
| Low | 0.0665 on 11/02/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 1.3800 on 08/09/22 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | +0.18% since 10/23/23 | -13.58% since 10/23/23 | +14.14% since 05/20/19 | +10.13% since 10/23/23 |
| Low | 0.0665 on 11/02/22 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 1.3800 on 08/09/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 145,845,984 | 83,357,904 | 77,035,920 | 103,362,928 |
| Shares Outstanding, K | 49,858 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 10,830,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -131,070,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 210,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -16,670,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 2.57 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 10.99 | 29.34 |